SCHEMBL5543918

SCHEMBL5543918

[CH2]Cc1ccc(CCc2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.56
MAOA P21397 3/20 0.56
FFAR1 O14842 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
ALOX12 P18054 1/20 0.50
CASP1 P29466 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 2/20 0.48
HTR2A P28223 2/20 0.48
CYP2A6 P11509 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
LOXL2 Q9Y4K0 1/20 0.48
KCNH2 Q12809 1/20 0.46
HDAC1 Q13547 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28114321 0.88 CALM1 (0.53) MAOBALDH1A1HPGDALOX15ALOX12
SCHEMBL28 0.88
SCHEMBL28202766 0.85
SCHEMBL21680909 0.85
SCHEMBL27686006 0.85
SCHEMBL9517116 0.85
SCHEMBL29270152 0.85
SCHEMBL28997420 0.85
SCHEMBL27769510 0.85
SCHEMBL27945561 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111491963-B Method for producing (meth) acrylic composition, coating material containing (meth) acrylic composition, and cured body 三菱瓦斯化学株式会社 2023-04-28 CN disclosed
US-20220145118-A1 (METH)ACRYLIC COMPOSITION, PAINT AND CURING AGENT COMPRISING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-05-12 US disclosed
US-11326073-B1 (meth)acrylic composition, paint and curing agent comprising same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-05-10 US disclosed
WO-2020218151-A1 (METH)ACRYLIC COMPOSITION, PAINT AND CURING AGENT COMPRISING SAME 三菱瓦斯化学株式会社 2020-10-29 WO disclosed
US-20190338157-A1 (METH)ACRYLIC COMPOSITION, COATING MATERIAL CONTAINING SAME AND CURED BODY MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-11-07 US disclosed
EP-3495397-A1 (METH)ACRYLIC COMPOSITION, COATING MATERIAL CONTAINING SAME AND CURED BODY Mitsubishi Gas Chemical Company, Inc. (JP) 2019-06-12 EP disclosed
US-10150865-B2 Resin composition and molded object obtained therefrom MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2018-12-11 US disclosed
CN-108822245-A (Methyl)Acrylic copolymer 三菱瓦斯化学株式会社 2018-11-16 CN disclosed
CN-105705580-B (meth) acrylic copolymer, resin composition, and molded article thereof 三菱瓦斯化学株式会社 2018-07-20 CN disclosed
EP-3279259-A1 RESIN COMPOSITION AND MOLDED OBJECT OBTAINED THEREFROM Mitsubishi Gas Chemical Company, Inc. (JP) 2018-02-07 EP disclosed
CN-106459553-B Poly carbonate resin composition and its formed body 三菱瓦斯化学株式会社 2018-01-19 CN disclosed
US-20170327685-A1 RESIN COMPOSITION AND MOLDED OBJECT OBTAINED THEREFROM MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2017-11-16 US disclosed
CN-106459553-A Polycarbonate resin composition and article molded therefrom 三菱瓦斯化学株式会社 2017-02-22 CN disclosed
CN-105705580-A (meth) acrylic copolymer, resin composition, and molded article thereof 三菱瓦斯化学株式会社 2016-06-22 CN disclosed
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
US-7262212-B2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-28 US disclosed
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-05-04 US disclosed
EP-1555267-A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-07-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094767-A1 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles NR2C2, NR4A3, NR4A2 MAOB 2140/4885MAOA 2885/4885FFAR1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.